Document is current
Any future updates will be listed below
-
Authors
Johnson, Mackenzie
Strunk, Andrew https://orcid.org/0000-0002-7547-031X
Garg, Amit https://orcid.org/0000-0003-0886-6856
- License Information
-
More Information
Article History
Received: 16 April 2025
Revised: 4 June 2025
Accepted: 20 August 2025
First Online: 13 September 2025
Declarations
:
: Mackenzie Johnson and Andrew Strunk have no conflicts of interest to disclose. Amit Garg is an advisor for AbbVie, Aclaris Therapeutics, Anaptys Bio, Aristea Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Incyte, Insmed, Janssen, Novartis, Pfizer, Sonoma Biotherapeutics, UCB, Union Therapeutics, Ventyx Biosciences, and Viela Biosciences, and receives honoraria. Dr Garg receives research grants from AbbVie, UCB, National Psoriasis Foundation, and CHORD COUSIN Collaboration (C3). He is co-copyright holder of the HS-IGA and HiSQOL instruments.
: This study was approved by the Institutional Review Board of the Feinstein Institutes for Medical Research at Northwell Health, approval number 24–0534.
: This study was granted an exemption from requiring written informed concert by the Institutional Review Board of the Feinstein Institute for Medical research at Northwell Health.
